Skip to main content
Clinical Trials/NCT05415995
NCT05415995
Recruiting
Not Applicable

A Prospective, Multicenter, Randomized Controlled Trail Using Drug-coated Balloon to Treat Below The Knee Arterial Stenosis or Occlusion

Zhejiang Zylox Medical Device Co., Ltd.20 sites in 1 country202 target enrollmentMarch 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Artery Disease
Sponsor
Zhejiang Zylox Medical Device Co., Ltd.
Enrollment
202
Locations
20
Primary Endpoint
Rate of primary patency of the target lesion
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This is a prospective, multicenter, randomized controlled trail using drug-coated balloon to treat below the knee arterial stenosis or occlusion.

Detailed Description

This trail is conducted in several centers all around China. 202 subjects with below the knee arterial stenosis or occlusion will be recruited and randomized, this trail compares the efficacy and safety of Drug-coated Balloon (Zylox-Tonbridge) with a similar balloon catheter producted by Acotec. The subjects will be followed up when discharged /in 30 days/ 6 months.

Registry
clinicaltrials.gov
Start Date
March 1, 2022
End Date
December 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Zhejiang Zylox Medical Device Co., Ltd.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18-85 years;
  • ≥70% diameter stenosis or occlusion in the target below-the-knee lesion;
  • Rutherford Category 3-6;
  • Subjects are willing to sign informed consent;

Exclusion Criteria

  • Planned major limb amputation within 30 days after the procedure;
  • In-stent stenosis in the target lesion;
  • Severely calcified target lesions;
  • Creatinine\>2.5mg/dL;
  • History of allergies to anesthetics, contrast agents;
  • Subjects who have participated in any other drug or medical device clinical investigations and haven't reach the primary endpoint;
  • Other circumstances judged by researchers that are not suitable for enrollment.

Outcomes

Primary Outcomes

Rate of primary patency of the target lesion

Time Frame: 180 days

Primary patency is defined as no target lesion occlusion, no clinical symptom driven target lesion revascularization and major limb amputation.

Secondary Outcomes

  • Success rate of the technique(Immediately after the intervention)
  • Success rate of the operation(Within 7 days)
  • Success rate of the device(Intraoperation)

Study Sites (20)

Loading locations...

Similar Trials